This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Life Technologies Acquires KDR Biotech Co., LTD., Leading Reagents Distributor

CARLSBAD, Calif., April 12, 2013 /PRNewswire/ --  Life Technologies Corporation (NASDAQ: LIFE) today announced the acquisition of KDR Biotech Co., Ltd., (KDR Biotech) a leading reagents distributor based in Seoul, Korea. KDR Biotech has been Life's primary reagent distributor in Korea since 1982.

The Korean biotechnology market has high potential—showing solid growth over the past five years and with the Korean government's Bio-vision 2016 initiative, it's anticipated to drive further growth in biotechnology investments within the country.

"The acquisition of KDR Biotech is in line with Life's Asia-Pacific Japan strategy to further develop customer relationships, improve the customer experience and increase revenue in the fast-growing South Korean biotechnology market, in addition to Life's overall strategy of expanding our footprint into strong growth and emerging markets," said Mark Smedley, president of Life Technologies, Asia-Pacific Japan region. "KDR Biotech will help us build a strong, leading brand in South Korea to propel us forward into sustainable growth."

Currently, KDR Biotech offers a complete solution to serve the many different needs of South Korean life science customers in academia, government research and within the industry. KDR Biotech's 30 years of market knowhow and experience in building customer relationships will assist in Life reaching out to an even larger customer base in the life science market in Korea. Life will also continue to offer non-Life products which had been part of KDR Biotech's portfolio, such as plastic ware and other complementary life science products which will maintain a competitive advantage in direct sales and to enhance the customer experience.  



All current KDR Biotech employees in the main office in Seoul and throughout Korea will become part of Life Technologies Korea and CEO, Mr. Jong-moon ( Arnold) Kim, will also serve as an external advisor to Life Technologies during the transition. Other terms of the acquisition are not being disclosed. 



1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,203.37 -85.26 -0.47%
S&P 500 2,107.78 -9.61 -0.45%
NASDAQ 4,979.9010 -28.1950 -0.56%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs